A History of Making History
BIACH & RI is at the forefront of today’s immunotherapy breakthroughs. Building on the strong foundations laid by our founders in tumor immunology, we continue to advance innovations that have already transformed the lives of millions of cancer patients—and hold the potential to benefit countless more in the future.
About Us
Advancing cancer research through scientific excellence, innovation, collaboration and translational research.
Indo-American Cancer Research Foundation
The Indo-American Cancer Research Foundation (IACRF) is a registered non-profit Trust established on December 27, 2014, under the Societies Registration Act of India.
It is officially recognized by NGO Darpan and the Department of Scientific and Industrial Research - Scientific and Industrial Research Organizations (DSIR-SIRO), India.
Founded with a vision to build a world-class translational cancer research institute, IACRF was established by an eminent board of globally renowned scientists, leading oncologists, and industrial leaders.
The foundation's core mission is to bridge the gap between laboratory discovery and clinical application, accelerating the drive against cancer through high-impact scientific inquiry.
Bridging the gap between laboratory discovery and clinical application to accelerate the fight against cancer.
A Multidisciplinary Research Foundation
IACRF brings together a multidisciplinary team of research professionals dedicated to undertaking, developing, and supporting basic, translational, applied, and socio-medical oncology research.
Its scientific endeavours encompass molecular oncology, targeted therapies, clinical trials, and epidemiological studies.
The foundation also supports initiatives aimed at improving early detection and making innovative cancer treatments accessible to low-resource communities.
- Molecular oncology
- Targeted therapies
- Clinical trials
- Epidemiological studies
- Early cancer detection
- Accessible cancer treatment research
Vision, Mission & Values
Our research activities are guided by a clear vision, purposeful mission and strong scientific values.
Vision
To be an effective world class clinical and translational cancer research center to further the drive against cancer.
Mission
- To make effective and significant contributions to fight against cancer.
- Develop newer and better strategies to identify cancer susceptible population, to intervene and treat cancer patients to alleviate their pain and suffering.
- Develop and innovate cancer preventative strategies.
Values
- Research will be carried out with Integrity, Commitment, and Diligence.
- Research priorities will be governed by National priorities and Global concerns, particularly related to Cancer.
- The institute shall foster creativity for innovation.
Objectives
The Foundation undertakes, develops, supports and promotes basic, fundamental, translational and applied oncology and medical research.
To carry on and/or promote special enquiries for oncological and/or related/associated diseases, their prevention, causation and spread, and remedy.
Early detection of cancer and associated medical conditions and diseases in rural, tribal and metropolitan areas and motivating people to seek medical help.
To undertake and promote fundamental, translational and applied research in all medical subjects, particularly relating to oncology.
To undertake research into the incidence and increased prevalence of various cancers and study strategies of prevention and cure, while increasing awareness about cancer.
To conduct research on the roles of tobacco, alcohol products, dietary habits, bacteria and viral infections in the causation of cancers.
To undertake research into the genetic and physical characteristics of human beings and their role in the causes of diseases.
To promote research and development of surgical and non-surgical kits for screening, diagnostic and therapeutic purposes in cancer care.
To promote research and development of specific, effective and low-cost early detection, diagnostic and treatment modalities using pharmacogenomic, pharmacogenetic and pharmaceutical approaches.
To detect various etiological, genetic, social and lifestyle factors that contribute to the genesis, spread, resistance and relapse of cancers.
Laboratory and clinical studies of cancers and malignancies.
To carry on research on surgical problems including the management of post-operative, chemotherapy and radiation care, particularly related to cancer.
To undertake epidemiological studies of diseases in India.
To conduct experimental studies to evolve effective and practicable methods of controlling malignancies, tumours and cancers in Indian conditions.
To promote research scholars, including pre-Ph.D., post-Ph.D. and other research activities.
Areas of Research Being Undertaken
Our research activities focus on advancing understanding, prevention, early detection and treatment of cancer.
Early Diagnosis
Alternative / Adjunct Therapies for Cancer
Cancer Metabolism
Genetic Basis of Cancer
Cancer Awareness & Prevention Programs
Advancing Cancer Research From Bench to Bedside
Through strategic collaborations with national and international medical centres, academic institutions and public health bodies, IACRF is committed to advancing cutting-edge cancer science from bench to bedside and contributing to improved patient outcomes worldwide.
Our Founders
Late Sri. Nandamuri Taraka Rama Rao Garu, the former Chief Minister of Andhra Pradesh, envisioned a world where quality cancer care would be accessible to all. This vision was deeply personal, as his wife, Smt. Nandamuri Basavatarakam Garu, was an unfortunate victim of cancer. In her loving memory, and inspired by her strength and grace, the Basavatarakam Indo American Cancer Hospital & Research Institute was established—dedicated to providing comprehensive, compassionate, and world-class cancer care to patients from all walks of life.
Governing Board / Board of Trustees
The Foundation is guided by an eminent board comprising distinguished scientists, oncologists, medical professionals and industry leaders.
| S. No. | Name | Profession / Occupation | Designation | Organisation |
|---|---|---|---|---|
| 1 | Dr. Ch. Mohan Rao |
Former Director, Centre for Cellular & Molecular Biology (CCMB) |
President | CSIR-CCMB |
| 2 | Shri J. S. R. Prasad | Industrialist | Treasurer | NBTRMCF |
| 3 | Dr. G. N. Rao | Distinguished Chair of Eye Health, L V Prasad Eye Institute | Member | LVP Eye Institute |
| 4 | Dr. B. Sesikeran | Former Director, National Institute of Nutrition (NIN-ICMR) | Member | Former Director, NIN |
| 5 | Dr. Dattatreyudu Nori | Radiation Oncologist | Member | Memorial Sloan Kettering Cancer Center, New York |
| 6 | Dr. Raghunadha Rao | Professor of Medical Oncology | Member | MNJ Institute of Oncology |
| 7 | Dr. Raghavendra S. Prasad | Director | Member | Medical Service Camps, Family Medicine, Waco, Texas |
| 8 | Dr. T. Subramanyeshwar Rao | Medical Director & Chief Surgical Oncologist | Member | Basavatarakam Indo-American Cancer Hospital & Research Institute |
| 9 | Dr. Senthil Rajappa | Chief Medical Oncologist | Member | Basavatarakam Indo-American Cancer Hospital & Research Institute |
Research Advisory Board
The Research Advisory Board provides scientific guidance and expertise to support the Foundation's research initiatives.
| S. No. | Name | Profession / Occupation | Designation | Organisation |
|---|---|---|---|---|
| 1 | Dr. Ch. Mohan Rao | Former Director, Centre for Cellular & Molecular Biology (CCMB) | President | Former Director, CSIR-CCMB |
| 2 | Dr. B. Sesikeran | Former Director, National Institute of Nutrition (NIN-ICMR) | Member | Former Director, NIN |
| 3 | Dr. Raghunadha Rao | Professor of Medical Oncology | Member | MNJ Institute of Oncology |
| 4 | Dr. T. Subramanyeshwar Rao | Medical Director & Chief Surgical Oncologist | Member | Basavatarakam Indo-American Cancer Hospital & Research Institute |
| 5 | Dr. Senthil Rajappa | Chief Medical Oncologist | Member | Basavatarakam Indo-American Cancer Hospital & Research Institute |